The Pharma Data

NOVEMBER 24, 2020

BRCA 1/2 or ATM gene mutation must be confirmed before Lynparza treatment is initiated. The Notice of Compliance was granted under priority review and marks the first Health Canada approval of a PARP inhibitor in prostate cancer. MISSISSAUGA, ON , Nov. ” . 3, 4, 5, 6 . ” .

Gene 52

Gene Hormones DNA Medicine 52

pharmaphorum

JULY 4, 2022

And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar. Navigating rare disease research and treatment.

Genome 105

Genome Genomics Research Medicine 105

pharmaphorum

MAY 18, 2022

Genomics has unlocked entirely new insights to what exactly may cause certain neurological conditions. Also, there is particular emphasis on exploring the potential of gene therapy to develop targeted treatments for these and further neurodegenerative conditions.

Gene Therapy 92

Gene Therapy Gene Genetics Development 92

Drug Discovery World

MARCH 27, 2023

Genomics is driving a revolution in drug development and, in the long run, the state of public healthcare. The first draft human genome took a decade to create, and 13 years to complete. Advances in sequencing are leading to scientific breakthroughs in preventative care, faster diagnoses, and proactive medical interventions.

Genome 52

Genome Genomics Research Scientist 52

Drug Discovery World

MAY 17, 2024

They concentrated on 718 genes often used in cancer genetic testing and incorporated mutations into their machine learning model. The need to protect this data isn’t just about compliance with laws like HIPAA or GDPR; it’s about maintaining trust. National Human Genome Research Institute. Accessed January 15, 2024.

Trials 59

Trials Clinical Trials Clinical Trials Protein 59

Drug Discovery World

JANUARY 23, 2024

The platform was recently updated to support FDA 21 CFR Part 11 compliance and include a full Installation Qualification / Operation Qualification (IQ/OQ) package for pharmaceutical quality assurance, extending the system’s applications into drug manufacturing operations. The consortium has been awarded €3.4

Compliance 52

Compliance Production Development Packaging 52

The Pharma Data

NOVEMBER 17, 2021

The companies will work GSK’s moxie in functional genomics and combine their capabilities in CRISPR webbing and artificial intelligence to identifyanti-coronavirus composites that target cellular host genes. They will also apply their concerted moxie to probe SARS-CoV-2 and other coronavirus vaccines.

Antibody 52

Antibody In-Vitro Vaccination Vaccine 52

Drug Discovery World

JUNE 6, 2023

In our collateral, we have 56 genes, those are SMBs; we show that we can pick up those SMBs at the same quality if we were doing a separate alone DNA assay. We’re still seeing those at the meeting at the moment”, he said, and thinks they still hold great promise for patients the better we understand patient genetics. It’s a 1.5

Protein 52

Protein DNA RNA Research 52

The Pharma Data

MAY 7, 2021

The EMA will assess the medicine’s compliance with the usual standards for efficacy, safety and quality. The companies will leverage GSK’s expertise in functional genomics and combine their capabilities in CRISPR screening and artificial intelligence to identify anti-coronavirus compounds that target cellular host genes.

Antibody 52

Antibody Trials Vaccination Vaccine 52

Pharmaceutical Technology

APRIL 27, 2023

Genomic medicine development was ranked as the top industry trend for 2023 in a survey of 198 GlobalData Pharma clients and prospects conducted between October and November 2022. GlobalData pharmaceutical analysts project that RNA-based gene therapies for oncology will grow from zero in 2022 to $4.6 billion by 2028.

Manufacturing 130

Manufacturing RNA Contamination Vaccination 130